Key result
LMB-96 chemotherapy protocol followed by biopsy of a residual mass resulted in complete remission at 3 months in a 10-year-old boy with cardiac Burkitt lymphoma.
Case Report (n=1)
Burkitt lymphoma can rarely present as an intracardiac mass, and early recognition with prompt chemotherapy can lead to complete remission.
Answers are grounded in this paper and cite their sources.
Does not support practice change from one case; extends sparse literature on pediatric cardiac Burkitt lymphoma.
Burkitt lymphoma manifesting as an intracardiac mass is a rare entity. This report describes the case of a 10-year-old boy who presented with an intracardiac mass and tumor thrombosis in the anterior mediastinum that proved to be Burkitt lymphoma. The LMB-96 chemotherapy protocol was given and at the end of the treatment there was still residual mass. A biopsy was performed and the pathology revealed thymus tissue. The patient has been in complete remission for 3 months. Burkitt lymphoma has a short doubling time and an intracardiac lesion can become life threatening. Early recognition and prompt treatment are crucial in achieving optimal outcomes.
No takes yet. Share an insight, caveat, or question.
Yozgat et al. (2018) conducted a case report in Burkitt lymphoma presenting with intracardiac mass and tumor thrombosis (n=1). LMB-96 chemotherapy protocol was evaluated on Complete remission. LMB-96 chemotherapy protocol followed by biopsy of a residual mass resulted in complete remission at 3 months in a 10-year-old boy with cardiac Burkitt lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: